Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production

Junichi Hirahashi, Toshio Nakaki, Keiichi Hishikawa, Takeshi Marumo, Matsuhiko Hayashi, Takao Saruta

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cytokines and cytokine-induced nitric oxide (NO) play important roles in inflammatory glomerular diseases, and both platelet-derived growth factor and transforming growth factor-β inhibit cytokine-induced NO production. In this study, we demonstrated that a selective endothelin ET(A) receptor antagonist, BQ-485 (Hexahydro-1H-azepinylcarbonyl-Leu-d-Trp-d-Trp-OH), reversed the inhibitory effect of platelet-derived growth factor on cytokine-induced NO production, but not that of transforming growth factor-β. Our findings suggest a difference between the inhibitory mechanisms of platelet-derived growth factor and transforming growth factor-β on cytokine-induced NO production. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)119-123
Number of pages5
JournalEuropean Journal of Pharmacology
Volume365
Issue number1
DOIs
Publication statusPublished - 1999 Jan 15

Fingerprint

Platelet-Derived Growth Factor
Nitric Oxide
Cytokines
Transforming Growth Factors
Endothelin A Receptor Antagonists

Keywords

  • Endothelin ET(A) receptor
  • Mesangial cells
  • Nitric oxide (NO)
  • Platelet-derived growth factor
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production. / Hirahashi, Junichi; Nakaki, Toshio; Hishikawa, Keiichi; Marumo, Takeshi; Hayashi, Matsuhiko; Saruta, Takao.

In: European Journal of Pharmacology, Vol. 365, No. 1, 15.01.1999, p. 119-123.

Research output: Contribution to journalArticle

Hirahashi, Junichi ; Nakaki, Toshio ; Hishikawa, Keiichi ; Marumo, Takeshi ; Hayashi, Matsuhiko ; Saruta, Takao. / Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production. In: European Journal of Pharmacology. 1999 ; Vol. 365, No. 1. pp. 119-123.
@article{18e3d77a48e14de79a372c79026cef35,
title = "Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production",
abstract = "Cytokines and cytokine-induced nitric oxide (NO) play important roles in inflammatory glomerular diseases, and both platelet-derived growth factor and transforming growth factor-β inhibit cytokine-induced NO production. In this study, we demonstrated that a selective endothelin ET(A) receptor antagonist, BQ-485 (Hexahydro-1H-azepinylcarbonyl-Leu-d-Trp-d-Trp-OH), reversed the inhibitory effect of platelet-derived growth factor on cytokine-induced NO production, but not that of transforming growth factor-β. Our findings suggest a difference between the inhibitory mechanisms of platelet-derived growth factor and transforming growth factor-β on cytokine-induced NO production. Copyright (C) 1999 Elsevier Science B.V.",
keywords = "Endothelin ET(A) receptor, Mesangial cells, Nitric oxide (NO), Platelet-derived growth factor, Transforming growth factor-β",
author = "Junichi Hirahashi and Toshio Nakaki and Keiichi Hishikawa and Takeshi Marumo and Matsuhiko Hayashi and Takao Saruta",
year = "1999",
month = "1",
day = "15",
doi = "10.1016/S0014-2999(98)00849-8",
language = "English",
volume = "365",
pages = "119--123",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production

AU - Hirahashi, Junichi

AU - Nakaki, Toshio

AU - Hishikawa, Keiichi

AU - Marumo, Takeshi

AU - Hayashi, Matsuhiko

AU - Saruta, Takao

PY - 1999/1/15

Y1 - 1999/1/15

N2 - Cytokines and cytokine-induced nitric oxide (NO) play important roles in inflammatory glomerular diseases, and both platelet-derived growth factor and transforming growth factor-β inhibit cytokine-induced NO production. In this study, we demonstrated that a selective endothelin ET(A) receptor antagonist, BQ-485 (Hexahydro-1H-azepinylcarbonyl-Leu-d-Trp-d-Trp-OH), reversed the inhibitory effect of platelet-derived growth factor on cytokine-induced NO production, but not that of transforming growth factor-β. Our findings suggest a difference between the inhibitory mechanisms of platelet-derived growth factor and transforming growth factor-β on cytokine-induced NO production. Copyright (C) 1999 Elsevier Science B.V.

AB - Cytokines and cytokine-induced nitric oxide (NO) play important roles in inflammatory glomerular diseases, and both platelet-derived growth factor and transforming growth factor-β inhibit cytokine-induced NO production. In this study, we demonstrated that a selective endothelin ET(A) receptor antagonist, BQ-485 (Hexahydro-1H-azepinylcarbonyl-Leu-d-Trp-d-Trp-OH), reversed the inhibitory effect of platelet-derived growth factor on cytokine-induced NO production, but not that of transforming growth factor-β. Our findings suggest a difference between the inhibitory mechanisms of platelet-derived growth factor and transforming growth factor-β on cytokine-induced NO production. Copyright (C) 1999 Elsevier Science B.V.

KW - Endothelin ET(A) receptor

KW - Mesangial cells

KW - Nitric oxide (NO)

KW - Platelet-derived growth factor

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=0033556392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033556392&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(98)00849-8

DO - 10.1016/S0014-2999(98)00849-8

M3 - Article

C2 - 9988130

AN - SCOPUS:0033556392

VL - 365

SP - 119

EP - 123

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -